These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18348242)

  • 1. "Antibodies--Europe. Engineering the next generation of antibodies".
    Moutel S; Perez F
    Biotechnol J; 2008 Mar; 3(3):298-300. PubMed ID: 18348242
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies.
    Chartrain M; Chu L
    Curr Pharm Biotechnol; 2008 Dec; 9(6):447-67. PubMed ID: 19075685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic antibodies: magic bullets hit the target.
    Gura T
    Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-generation monoclonals less profitable than trailblazers?
    Mitchell P
    Nat Biotechnol; 2005 Aug; 23(8):906. PubMed ID: 16082347
    [No Abstract]   [Full Text] [Related]  

  • 5. Tunable antibodies.
    Weiner LM; Carter P
    Nat Biotechnol; 2005 May; 23(5):556-7. PubMed ID: 15877072
    [No Abstract]   [Full Text] [Related]  

  • 6. Can next-generation antibodies offset biosimilar competition?
    Mullard A
    Nat Rev Drug Discov; 2012 Jun; 11(6):426-8. PubMed ID: 22653202
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein Engineering for Biotherapeutics--IBC's second annual conference. Developing and improving next generation biotherapeutics.
    Smider V
    IDrugs; 2007 Mar; 10(3):176-7. PubMed ID: 17351870
    [No Abstract]   [Full Text] [Related]  

  • 8. Mike Varney.
    Varney M; Mullard A
    Nat Rev Drug Discov; 2015 Mar; 14(3):158-9. PubMed ID: 25677359
    [No Abstract]   [Full Text] [Related]  

  • 9. Design and manufacture of monoclonal antibodies for radioimmunotherapy.
    Hale G; Berrie E; Bird P
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 11. [EMABling
    de Romeuf C
    Med Sci (Paris); 2019 Dec; 35(12):1160-1162. PubMed ID: 31903931
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: between molecular and macroscopic protein engineering.
    Jungbauer A
    Biotechnol J; 2008 Feb; 3(2):143. PubMed ID: 18283675
    [No Abstract]   [Full Text] [Related]  

  • 13. Commercial proteases: present and future.
    Li Q; Yi L; Marek P; Iverson BL
    FEBS Lett; 2013 Apr; 587(8):1155-63. PubMed ID: 23318711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage display derived therapeutic antibodies.
    Thie H; Meyer T; Schirrmann T; Hust M; Dübel S
    Curr Pharm Biotechnol; 2008 Dec; 9(6):439-46. PubMed ID: 19075684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the chemical biology core facility at EMBL: a vision for a European roadmap.
    Lewis JD
    ACS Chem Biol; 2007 Jan; 2(1):21-3. PubMed ID: 17243779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biologics--the new horizon for medical therapy].
    Ziegenhagen DJ
    Versicherungsmedizin; 2009 Mar; 61(1):4-9. PubMed ID: 19370838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bioLOGIC Europe 2007--Terrapinn's eighth annual conference.
    Mackay J
    IDrugs; 2007 Aug; 10(8):543-8. PubMed ID: 17665328
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV drugs made in tobacco.
    Fox JL
    Nat Biotechnol; 2011 Oct; 29(10):852. PubMed ID: 21997611
    [No Abstract]   [Full Text] [Related]  

  • 19. New technologies for the engineering of novel protein therapeutics and the personalization of medicine.
    Dorner AJ; Projan S
    Curr Opin Pharmacol; 2008 Oct; 8(5):598-9. PubMed ID: 18773971
    [No Abstract]   [Full Text] [Related]  

  • 20. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.